Live Breaking News & Updates on European medicines agency on

Stay informed with the latest breaking news from European medicines agency on on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in European medicines agency on and stay connected to the pulse of your community

Acurx Pharmaceuticals (ACXP) Granted FDA End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection

Acurx Pharmaceuticals (ACXP) Granted FDA End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Davidp-luci , Robertj-deluccia , Trial-oversight-committee , Acurx-pharmaceuticals-inc , Nasdaq , Data-monitoring-committee , Company-scientific-advisory-board , European-medicines-agency-on , Drug-administration , Acurx-pharmaceuticals

Novo to invest $6B to expand facilities | The Arkansas Democrat-Gazette

Novo Nordisk A/S will invest more than $6 billion to expand its manufacturing facilities as it fights to maintain dominance of a weight-loss market that's expected to hit $100 billion by 2030.

Denmark , Kalundborg , Sjæand , United-states , Copenhagen , Køavn- , American , Americans , Robert-langreth , Fruergaard-jorgensen , Madison-muller , Eli-lilly

The secrets of forever young 'superagers'

The secrets of forever young 'superagers'
euractiv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.com Daily Mail and Mail on Sunday newspapers.

Madrid , Spain , Slovenia , Bucharest , Bucuresti , Romania , Ukraine , France , Paris , France-general- , Las-palmas , Canarias

Eisai : Lecanemab Receives Priority Review Status In Japan For Alzheimer's Disease Treatment

(RTTNews) - Eisai Co., Ltd. and Biogen Inc. (BIIB) said that an application for manufacturing and marketing approval for an anti-amyloid-ß (Aß) pr...

China , Japan , Japanese , Eisai-co-ltd , Drug-administration-on , Japanese-ministry-of-health , European-medicines-agency-on , Devices-agency , Biogen-inc , More-such-health-news , Priority-review

Eisai: Lecanemab Receives Priority Review Status In Japan For Alzheimer's Disease Treatment

WESTON (dpa-AFX) - Eisai Co., Ltd. and Biogen Inc. (BIIB) said that an application for manufacturing and marketing approval for an anti-amyloid-? (A?) protofibril antibody, lecanemab (generic name

China , Japan , Japanese , Eisai-co-ltd , Drug-administration-on , Japanese-ministry-of-health , European-medicines-agency-on , Devices-agency , Biogen-inc , More-such-health-news , Priority-review

Japanese dengue vaccine gets European recommendation

The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.

United-states , Philippines , Japan , Indonesia , London , City-of , United-kingdom , Japanese , American , Sanofi-pasteur , World-health-organization , European-medicines-agency-on